Investigational Site Number 616003

Lublin 20-954

0 studies enrolling now · 4 studies all time

What they study most

Non-small Cell Lung Cancer, Relapsing-remitting Multiple Sclerosis, Small Cell Lung Cancer

Studies at this site

• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early
• Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 — Stopped early
• Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed
• Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer — Completed